ABA 0.00% $5.15 abano healthcare group limited

Ann: RELINT: ABA: Ongoing Disclosure Notice - E.K

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. lightbulb Created with Sketch. 2
    • Release Date: 01/02/13 15:24
    • Summary: RELINT: ABA: Ongoing Disclosure Notice - E.K. van Arkel
    • Price Sensitive: No
    • Download Document  1.89KB
    					
    
    ABA
    01/02/2013 13:24
    RELINT
    
    REL: 1324 HRS Abano Healthcare Group Limited
    
    RELINT: ABA: Ongoing Disclosure Notice - E.K. van Arkel
    
    Ongoing Disclosure Notice
    Disclosure of Directors and Officers Relevant Interests
    Section 19T(2), Securities Markets Act 1988
    
    A Details of director or officer
    Name of director or officer of public issuer:  Eduard Koert van Arkel
    Name of public issuer: Abano Healthcare Group Limited
    Name of related body corporate (if applicable):  N/A
    Position held in public issuer:  Director
    
    B Securities in public issuer or related body corporate to which this
    disclosure relates
    Number, class, and type of securities: 19 Ordinary Shares
    
    C Nature of relevant interest and name of registered holder
    Nature of relevant interest in those securities:  Registered holder &
    beneficial owner
    Name of registered holder of those securities  Eduard Koert van Arkel
    
    D Details of acquisitions and disposals
    If the relevant interest was acquired--
    Date of acquisition:  29 January 2013
    Consideration paid for acquisition:   $6.41 per share
    
    If the relevant interest was disposed of--
    Date of disposal:   N/A
    Consideration received for disposal:   N/A
    
    Type of transaction
    Describe the arrangement pursuant to which, or the circumstances in which,
    the acquisition or disposal took place:   Issue of shares pursuant to
    participation in the Dividend Reinvestment Plan for the 2013 interim dividend
    
    E Total number of transactions this notice relates to:  1 transaction
    
    F Date of last disclosure notice (whether in form 1 or form 2) by the
    director or officer:   28 August 2012
    
    G Signature
    Signature of director or officer:
    Date of signature:
    or
    Signature of person authorised to sign on behalf of director or officer:
    Date of signature:  1 February 2013
    Name and title of authorised person:  "Richard Keys
    Chief Operating Officer / Chief Financial Officer"
    End CA:00232544 For:ABA    Type:RELINT     Time:2013-02-01 13:24:53
    				
 
watchlist Created with Sketch. Add ABA (NZSX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.